Clinical trial

Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With…

NCT00249730 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed

Key facts

NCT number NCT00249730
Title Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function.
Official title A Prospective Multicenter, Parallel Group Study With A Single Blind Phase And A Double Blind Randomised Phase, To Evaluate The Efficacy And Satisfaction Of Viagra (Sildenafil Citrate) High Dose (100mg) Titration Compared With 50mg Dose, In Men With Erectile Dysfunction
Lead sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Impotence
Intervention type Drug
Interventions Sildenafil
Enrollment 510
Start date Oct 1, 2005
First posted Nov 7, 2005
Last update posted Feb 1, 2021
Countries Canada, France, Greece, Israel, Italy, Russia, Spain, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies